Tumour biomarkers – Page 3 – Ad Ma Place

Intratumoral and peritumoral PET/CT-based radiomics for non-invasively and dynamically predicting immunotherapy response in NSCLC

We aimed to develop a machine learning model based on intratumoral and peritumoral ¹⁸F-FDG PET/CT radiomics to non-invasively and dynami…

AdMaPlace March 9, 2025

0 Comments

Significance of homologous recombinant deficiency as a biomarker for drug sensitivity in colorectal cancer

Colorectal cancer (CRC) is a substantial global health concern due to its limited treatment options, especially for oxaliplatin (L-OHP) regimen res…

AdMaPlace March 9, 2025

0 Comments

GDP-bound Rab37 modulates M2-like tumor-associated macrophage polarization by attenuating STAT1 translocation to downregulate the type I IFN pathway

Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) primarily polarize into the M2-phenotype. Our previous study showed that th…

AdMaPlace March 9, 2025

0 Comments